Tandem Diabetes Care (TNDM) Non Operating Investment Income (2014)
Tandem Diabetes Care's (TNDM) quarterly Non Operating Investment Income came in at $6529.0 in Q3 2014, up 520.95% quarter-over-quarter from -$1551.0 in Q2 2014.
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Non Operating Investment Income (2014) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Non Operating Investment Income for 1 consecutive years, with $6529.0 the latest figure, recorded in Q3 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.72 Bn | 122.50 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.88 Bn | 108.06 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.10 Bn | 100.62 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.74 Bn | 63.20 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.60 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.15 Bn | 30.20 Bn | 830.00 Mn | - |
| 9 | Steris | 20.63 Bn | 20.15 Bn | 684.20 Mn | - |
| 10 | Tandem Diabetes Care | 1.27 Bn | 815.53 Mn | 144.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2014 | 6,529.00 |
| Jun 30, 2014 | -1,551.00 |
| Mar 31, 2014 | 13,833.00 |